I think the most accurate statement that the consensus is that revenue is in jeopardy.
It's not an article talking about the science, it's reporting on analyst opinions. It also mentions itself that the opinions should be taken with a grain of salt.
Is anything I've said inaccurate?
Also, new threads pop up all the time, but not an issue for those around here when it's for "upramping" rather than "downramping".
I agree, there should be two threads only, one for charts and one for discussion (maybe one for banter as well). But that's not how MSBs HC threads are organised
News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-14
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |